Here are answers to some of the most common questions from first-time users and experienced biohackers alike
TABLE 1 Current and emerging therapeutic agents targeting molecular mechanisms in Parkinsons disease
However, the small sample-size, the short treatment period, the absence of control groups, the lack of liver biopsy evaluation after treatment are just some of the limitations of these studies
Pedro Perez and his team are applying their advanced liposomal technology to glutathione , the body's master antioxidant
Delaying administration by six hours shifts the peptide's distribution profile toward liver, adipose, and other non-muscle tissues where IGF receptors remain at baseline expression
The platform handles appointment scheduling and basic communication